Belite Bio, Inc Payments of Stock Issuance Costs
Belite Bio, Inc (BLTE) reported Payments of Stock Issuance Costs of $1.03 million for the 12-month period ending 2022-12-31, per its 20-F filed 2025-03-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-03-17
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2022-12-31 | $1.03M 20-F · filed 2025-03-17 |
| 2021-12-31 | $815.00K 20-F · filed 2024-03-12 |